← SynDRA
PUMOSETRAG
SynDRA canonical compound SYN0026001 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HTR3A | HTR4 |
|---|
| Mechanism of action | serotonin receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- serotonin receptor agonist
Cross-references
Synonyms
- Ddp733
- DDP-733
- MKC-733
- N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]-7-oxo-4H-thieno[3,2-b]pyridine-6-carboxamide
- N-((3R)-1-Azabicyclo(2.2.2)oct-3-yl)-7-oxo-4,7-dihydrothieno(3,2-b)pyridine-6-carboxamide
- N-(1-azabicyclo[2.2.2]oct-8-yl)-2-oxo-9-thia-5-azabicyclo[4.3.0]nona-3,7,10-triene-3-carboxamide
- MKC 733
- DDP 733
- 1G26B32139
- PUMOSETRAGUM
- RefChem:585229
- DTXCID3087702
- Pumosetrag [INN]
- UNII-1G26B32139
- SCHEMBL390615
- DDP733
- orb2814755
- SCHEMBL1497797
- BDBM50334438
- EX-A10274
- HY-105083A
- CS-0024934
- NS00068160
- T202958
- BRD-K44164034-003-01-1
- SCHEMBL1497905
- Pumosetrag HCl
- CS-7917
- Pumosetrag hydrochloride
- MFCD00939557
- UNII-UVW44TKU66
- DA-67016
- HY-19650
- pumosetrag hydrochloride
- MS-25179
- AKOS025401708
- MKC-773
- SCHEMBL1299759
- EX-A10274A
Look up PUMOSETRAG in the interactive SynDRA portal →